Publication abstract
Subject class: Biotech, Life Sciences, Business Development, Funding
Life Science Research Markets and Analyses: Central & Eastern European Countries – ABA 309
Huckle D
Adams Business Associates: Global Library of World, National and Regional in depth Information and Market Analyses.
(256 pages). Price: GB £ 1,250 [single site licence], GB £ 1,900 [Multi-site licence)
Target audience: Chief executives, marketing and sales managers, business development managers, investors and analysts.
This is a regional report from a library of Global, National and Regional Analyses and is a fully integrated report covering the markets to the end of 2007.
This report covers the Reagents and Equipment Markets within the Central and Eastern European Life Science and Biotechnology sectors.
The primary objective of the report is to discuss the countries within this developing region by profiling each country by the development of its
Political, Demographic Investment, Technology Status, Healthcare Structure and Life Science Research Activities. The 28 countries included are:
Albania, Armenia, Azerbaijan, Belarus, Bosnia, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Hungary, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan. There is also an Appendix for Cyprus and Malta.
This Report brings together several earlier Reports that dealt separately with the 10 EU Accession Countries (ABA 236, which is why Cyprus and Malta are included in an Appendix), Croatia (ABA 266) and Russian Federation (ABA 259).
Commercial development and Funding systems are pitted against the focus of Life Science research, emerging and established products and companies. Research Market Quantification is discussed with segment distribution, products and commercial activity. A key is the detailed explanation of the structure of the Life Science sector in each country and where the various market segments and sources of funds are intermixed for the market dynamics.
The range of countries have very different political and cultural situations, with some as young and brand new members of the EU, others preparing for EU membership in the near future whilst others are part of the CIS States with continued links with the “new” Russia. There are major differences in the economic positions of these countries from the poorest in Europe to the major economies of Russia and the big three new EU members of the Czech Republic, Hungary and Poland.
Almost every country has either a strategy for Biotechnology or it is part of future overall economic plans. and the need to develop local procedures to enhance the economic development of these countries. The countries are examined in groups based on economic size and/or geographical and political positions. All countries are examined in the greatest detail that could be secured with the inevitable depth of information greatest for
Group 1 – Czech Republic, Hungary, Poland and Russia.
Group 2 – Estonia, Latvia, Lithuania, Slovakia and Slovenia.
Trends and Issues, Market Segmentation by Country or Region, Applications or customers are explained within the multi layered sector of Life Sciences.
Included are details on Pharmaceuticals, Research Reagents, Equipment, Bioinformatics, Services, Diagnostics, Medical Devices, Agriculture,
Biotechnology, as well as the Economic and Political aspects and much more.
This is the first detailed analysis of the Life Science/Biotechnology sector for this whole market region and will continue to be updated during 2008 with the free Update to be made available in January 2009.
All Global Library reports include market and user segment quantification and projections, commercial aspects and regional, company or institute profiles.
close